Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target

Secretory clusterin (sCLU) is associated with hepatocellular carcinoma (HCC) progression by contributing to angiogenesis, chemoresistance, cell survival, and metastasis. However, the sCLU expression at early stage of HCC progression remains to be clarified. In this study, the alteration of sCLU onco...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Zheng, Wenjie, Yao, Min, Qian, Qi, Sai, Wenli, Qiu, Liwei, Yang, Junling, Wu, Wei, Dong, Zhizhen, Yao, Dengfu
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2016
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5581031/
https://ncbi.nlm.nih.gov/pubmed/28881732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13674
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares